i like this!
This signals the advancement of IMP761 towards Good Manufacturing Practice (GMP) manufacturing and clinical development for the treatment of autoimmune diseases by Immutep and follows new and encouraging preclinical results that demonstrate the immunosuppressive activity of IMP761 in vivo.
Ann: Progress towards clinical development of IMP761, page-2
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.8¢ | 30.3¢ | $537.2K | 1.728M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 43201 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 541277 | 36 |
View Market Depth
| Last trade - 12.38pm 27/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
